Skip to content

Development of Alcohol Use Disorders: the role of clinical, psychological, environmental and neurobiological factors; an fMRI substudy

Development of Alcohol Use Disorders: the role of clinical, psychological, environmental and neurobiological factors; an fMRI substudy - Neurobiological factors in alchohol use disorders; an fMRI study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON33738
Enrollment
80
Registered
2009-03-02
Start date
2009-09-25
Completion date
Unknown
Last updated
2024-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alcohol dependency depression

Interventions

A part of the patients will be asked not to drink any alcohol 24 hours prior to the research.

Sponsors

Vrije Universiteit Medisch Centrum
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Per group: (I) current DSM-IV diagnosis alcohol dependency and 6 month DSM-IV diagnosis of depression and/ or anxiety disorder; (II) 6-month DSM-IV diagnosis depression and/or anxiety disorder; (III) No DSM-IV psychiatric disorder

Exclusion criteria

Exclusion criteria: (a) the use of psychotropic medication except for selective serotonin reuptake inhibitors in stable dosage, (b) major internal or neurological disorder, (c) known contra-indications for MR investigations, such as the presence of metal objects (e.g. pacemaker, arteriovenous clips), or claustrophobia

Design outcomes

Primary

MeasureTime frame
Behavioural data and Blood Oxygenated Level Dependent (BOLD)-response, recorded using fMRI, will be measured. These, and behavioural data are correlated with chronicity of alcohol dependence in order to investigate weather differences in several cognitive and motivational activities underlie the differences in chronicity of alcohol dependence.

Secondary

MeasureTime frame
nvt

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)